Merck & Co., Inc. Revenue 2007–2025
Merck & Co., Inc. annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Merck & Co., Inc. revenue for the quarter ending March 31, 2026 was 16.3 B, a 4.87% increase year-over-year.
- Merck & Co., Inc. revenue for the twelve months ending March 31, 2026 was 64.9 B, a 0.61% increase year-over-year.
- Merck & Co., Inc. annual revenue for 2025 was 65.0 B, a 1.31% increase from 2024.
- Merck & Co., Inc. annual revenue for 2024 was 64.2 B, a 6.74% increase from 2023.
- Merck & Co., Inc. annual revenue for 2023 was 60.1 B, a 1.40% increase from 2022.
- Merck & Co., Inc. annual revenue for 2022 was 59.3 B.
Merck & Co. Inc. (MRK) — Frequently Asked Questions
Merck & Co. Inc. (MRK) is a publicly traded US company in the Healthcare sector. It has a market capitalization of $306.27B. In fiscal 2025 it reported revenue of $65.01B and net income of $18.25B. Explore MRK's stock price, financial statements, earnings history, margins and key ratios below.
What is Merck & Co. Inc.'s market cap?
Merck & Co. Inc. (MRK) has a market capitalization of $306.27B.
What is the MRK stock price?
MRK trades at $122.17 (+2.58% on the day).
How much revenue does Merck & Co. Inc. make?
Merck & Co. Inc. reported revenue of $65.01B in fiscal 2025.
Is MRK profitable?
In fiscal 2025, Merck & Co. Inc. reported net income of $18.25B.
What is MRK's P/E ratio?
Based on diluted EPS, MRK has a price-to-earnings (P/E) ratio of about 16.8.